Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| 1,1-Dimethylethyl N-[(3R)-1-[(2-cyanophenyl)methyl]-3-piperidinyl]carbamate | An impurity of alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor in the class of oral antidiabetic drugs. Group: Pharmaceutical. CAS No. 1353254-15-5. Pack Sizes: 100 mg. Product ID: B1370-425896. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| 2-[[3, 4-Dihydro-3-methyl-2, 4-dioxo-6-[ (3R)-3-piperidinylamino]-1 (2H)-pyrimidinyl]methyl]benzonitrile | An impurity of alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor in the class of oral antidiabetic drugs. Group: Pharmaceutical. CAS No. 2089611-85-6. Pack Sizes: 100 mg. Product ID: B1370-425895. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (2'R,2S,cis)-Saxagliptin | An impurity of Saxagliptin. Saxagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) used as a hypoglycemic drug. It was approved to treat type 2 diabetes. Group: Pharmaceutical. CAS No. 1564265-93-5. Pack Sizes: 2.5 mg. Product ID: B0016-007240. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (2R)-Vildagliptin | (2R)-Vildagliptin is an R-enantiomer of Vildagliptin, which is a dipeptidyl peptidase-4 (DPP-4) inhibitor used as an anti-hyperglycemic agent and an anti-diabetic drug. Group: Pharmaceutical. CAS No. 1036959-27-9. Pack Sizes: 20 mg. Product ID: B0020-461928. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 3-Deoxy Saxagliptin | An impurity of Saxagliptin. Saxagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) used as a hypoglycemic drug. It was approved to treat type 2 diabetes. Group: Pharmaceutical. CAS No. 361441-98-7. Pack Sizes: 2.5 mg. Product ID: B0016-007241. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 4-((2-Hydroxyethoxy)carbonyl)benzoic acid | 4-((2-Hydroxyethoxy)carbonyl)benzoic acid, an essential pharmaceutical intermediate widely utilized for synthesizing dipeptidyl peptidase-4 (DPP-4) inhibitors, possesses potential anti-cancer properties with its pronounced efficacy in chronic myeloid leukemia (CML) and other cancer treatments. Plausible and encouraging observations in cancer research elucidate its immense promise as a therapeutic agent. Group: Pharmaceutical. CAS No. 1137-99-1. Pack Sizes: 100 mg. Product ID: B2699-223434. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Aaf-Arg-OH HCl | Aaf-Arg-OH HCl, a substrate of carboxypeptidase B-type enzymes, has been used to determine the activation of TAFI (thrombin activatable fibrinolysis inhibitor, carboxypeptidase U) by thrombin and thrombin-thrombomodulin. Group: Pharmaceutical. CAS No. 442158-31-8. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-015297. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| AAF-CMK trifluoroacetate salt | AAF-CMK is a serine protease inhibitor which irreversibly inhibits TPPII (tripeptidyl peptidase II), a giant protease which may substitute for some proteasome function, and reversibly inhibits Cln2 (TPPI). Group: Pharmaceutical. CAS No. 184901-82-4. Pack Sizes: 100 mg. Product ID: BAT-015706. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Abz-Ala-Gly-Leu-Ala-p-nitrobenzylamide | Abz-Ala-Gly-Leu-Ala-p-nitrobenzylamide is a fluorogenic substrate for neutral metalloendopeptidases. Group: Pharmaceutical. CAS No. 100307-95-7. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-014964. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acetyl 1-L-leucyL-L-arginine | Acetyl 1-L-leucyL-L-arginine is a lactone compound isolated from the Bacterium sp. BMG520-yF2. Acetyl 1-L-leucyL-L-arginine has the activity of inhibiting dipeptidyl aminopeptidase ?. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-00009. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Acetyl-L-tyrosine ethyl ester hydrate | A substrate for chymotrypsin and carboxypeptidase Y. Group: Pharmaceutical. CAS No. 36546-50-6. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-003907. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ac-Gly-Pro-AFC | Ac-Gly-Pro-AFC is a specific substrate for the endopeptidase activity of fibroblast activation protein (FAP) (Km = 330±30 μM; kcat = 7.7±0.2 s-1). Group: Pharmaceutical. CAS No. 886993-02-8. Pack Sizes: 1mg; 1g; 10g. Product ID: BAT-014564. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Actinonin | Actinonin, a natural antibacterial agent produced by Actinomyces, is a potent reversible peptide deformylase (PDF) inhibitor with Ki of 0.28 nM. Actinonin inhibits aminopeptidase M, aminopeptidase N and leucine aminopeptidase. Actinonin also inhibits MMP-1, MMP-3, MMP-8, MMP-9, and hmeprin α with Ki of 300 nM, 1,700 nM, 190 nM, 330 nM, and 20 nM, respectively. Actinonin induces apoptosis and has antiproliferative and antitumor activities. Uses: Anti-bacterial agents. Group: Pharmaceutical. CAS No. 13434-13-4. Pack Sizes: 1mg; 1g; 10g. Product ID: BBF-00543. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Antagonist G | Antagonist G is a substance P analog, which is a broad spectrum neuropeptide growth factor antagonist and antiproliferative agent. It was developed for the treatment of small cell lung cancer. It could inhibit neuropeptide-dependent and -independent proliferation of small cell lung cancer in vitro. It also inhibits growth of SCLC xenografts in mice in vivo. It blocks Swiss 3T3 cell growth induced by vasopressin, gastrin-releasing peptide and bradykinin. It activates JNK and stimulates apoptosis. It is an anticancer agent and is resistant to degradation by peptidases. Group: Pharmaceutical. CAS No. 115150-59-9. Pack Sizes: 1 mg. Product ID: BAT-006104. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Baicalein | Baicalein (5,6,7-trihydroxyflavone) is a flavone, a type of flavonoid, originally isolated from the roots of Scutellaria baicalensis and Scutellaria lateriflora. Baicalein is a CYP2C9 and prolyl endopeptidase inhibitor. Baicalein is a natural compound and can be used in cosmestics material. Uses: Neuroprotective; anticancer. Group: Pharmaceutical. CAS No. 491-67-8. Pack Sizes: 5 g. Product ID: NP1936. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bestatin | Bestatin is a specific aminopeptidase B inhibitor produced by Streptomyces olivoreticuli. Bestatin is a potent aminopeptidase-B and leukotriene (LT) A4 hydrolase inhibitor used in the treatment of acute myelocytic leukemia. It exhibits potential immunomodulatory and antitumor activities. Uses: The treatment of acute myelocytic leukemia. Group: Pharmaceutical. CAS No. 58970-76-6. Pack Sizes: 1 g. Product ID: BAT-015664. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bestatin hydrochloride | Bestatin hydrochloride is a competitive aminopeptidase inhibitor, which is studied for use in the treatment of acute myelocytic leukemia. It has become a useful tool in elucidating the physiological role of some mammalian exopeptidases in the regulation of the immune system, in the growth of tumors and their invasion of surrounding tissues, and in the degradation of cellular proteins. Group: Pharmaceutical. CAS No. 65391-42-6. Pack Sizes: 100 mg. Product ID: BAT-010264. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bestatin Impurities | Bestatin Impurities are critical in the biomedical industry for quality control during the production of Bestatin, a known inhibitor of aminopeptidase enzymes. These impurities help ensure the drug's efficacy and safety in treating various cancers and as an adjunct therapy for enhancing immune response against infections. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-Saxagliptin | An impurity of saxagliptin. Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type II diabetes. Group: Pharmaceutical. CAS No. 709031-43-6. Pack Sizes: 25 mg. Product ID: B1370-149516. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ceftobiprole medocaril sodium | Ceftobiprole medocaril sodium is a water-soluble prodrug ceftobiprole, a 5th-generation cephalosporin for the treatment of hospital-acquired pneumonia (excluding ventilator-associated pneumonia) and community-acquired pneumonia. Ceftobiprole binds to penicillin-binding proteins (PBPs) and inhibits their transpeptidase activity. Group: Pharmaceutical. CAS No. 252188-71-9. Pack Sizes: 10 mg. Product ID: B2692-292584. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cilastatin Ammonium Salt | Cilastatin Ammonium Salt is the ammonium salt of Cilastatin, which is a dipeptidase inhibitor of renal enzyme dehydropeptidase-I and leukotriene D4 peptidase. It inhibits metabolism of LTD4 to LTE4 and the hydrolysis of β-lactam antibiotics. It reduces toxic accumulation of cyclosporin A in kidney proximal tubule epithelial cells. It can be combined intravenously with imipenem in order to protect it from dehydropeptidase. It suppresses both host and target metabolism of the broad-spectrum antibiotic imipenem, improving its efficacy. It usually confers antibiotic resistance to certain bacteria because itself does not have antibiotic activity. It has nephroprotective effects. Group: Pharmaceutical. CAS No. 877674-82-3. Pack Sizes: 500 mg. Product ID: B2693-468925. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cilastatin sodium | Cilastatin sodium is the sodium salt of cilastatin, which is a dipeptidase inhibitor of renal enzyme dehydropeptidase-I and leukotriene D4 peptidase. It inhibits metabolism of LTD4 to LTE4 and the hydrolysis of β-lactam antibiotics. It reduces toxic accumulation of cyclosporin A in kidney proximal tubule epithelial cells. It can be combined intravenously with imipenem in order to protect it from dehydropeptidase. It suppresses both host and target metabolism of the broad-spectrum antibiotic imipenem, improving its efficacy. It usually confers antibiotic resistance to certain bacteria because itself does not have antibiotic activity. It has nephroprotective effects. Group: Pharmaceutical. CAS No. 81129-83-1. Pack Sizes: 1 g. Product ID: B0084-077802. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Cysteinyl-3M3SH | Cysteinyl-3M3SH is an intermediate in the bacterial biotransformation of the odourless physiological malodour precursor Cys-Gly-3M3SH. Cys-Gly-3M3SH is actively transported by the di-/tri-peptide transporter (DtpT) along with the movement of protons. Once inside the cell the terminal glycine is cleaved by a dipeptidase (PepA) to release Cys-3M3SH. Group: Pharmaceutical. Pack Sizes: 250 mg. Product ID: BAT-014377. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Diprotin A | It is produced by the strain of Bacillus cereus BMF 657-RF1. It can inhibit Dipeptidyl amino peptidase IV and immune enhancement effect. Group: Pharmaceutical. CAS No. 90614-48-5. Pack Sizes: 500 mg. Product ID: BAT-010802. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-Dha-OH | Fmoc-Dha-OH, a pivotal intermediate, is used for synthesizing a plethora of biologically active compounds encompassing antimicrobial peptides, dipeptidyl peptidase IV inhibitors, and enzyme inhibitors. Researchers have employed it to fabricate Fmoc-Dha-OH-derived peptidomimetics manifested by the impeding activity against a myriad of cancer cell lines. The said compound holds sheer potential for the design and development of novel pharmaceutical agents targeting numerous diseases. Group: Pharmaceutical. CAS No. 261522-33-2. Pack Sizes: 500 mg. Product ID: BAT-008269. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Glutathione EP Impurity C | Oxiglutatione is a stabilized formulation of disodium glutathione disulfide (GSSG; oxidized glutathione) and cisplatin (1000:1) with potential chemoprotective and immunomodulating activities. Mimicking endogenous GSSG, Oxiglutatione acts as a competitive substrate for gamma-glutamyl-transpeptidase (GGT), which may result in the S-glutathionylation of proteins, predominantly actin, a redox stress on endoplasmic reticulum (ER), and ER stress-induced apoptosis. S-glutathionylation may be stimulated by reactive oxygen species (ROS) liberated by an oxiglutatione-induced increase in GGT activity. Oxiglutatione may also induce phosphorylation of proteins such as ERK and p38, two kinases that play critical regulatory roles in cell proliferation and apoptosis. The cisplatin component of this agent does not provide an effective therapeutic concentration of cisplatin in vivo. Group: Pharmaceutical. CAS No. 27025-41-8. Pack Sizes: 25 g. Product ID: B0084-064728. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| H-Gly-Pro-Hyp-OH | A peptide inhibitor of dipeptidylpeptidase-IV (DPP-IV). Group: Pharmaceutical. CAS No. 2239-67-0. Pack Sizes: 500 mg. Product ID: BAT-015714. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ilomastat | Ilomastat is a broad-spectrum matrix metalloproteinase inhibitor, displaying potential anticancer activity. Ilomastat is a member of the hydroxamic acid class of reversible metallopeptidase inhibitors. The anionic state of the hydroxamic acid group forms a bidentate complex with the active site zinc. Ilomastat inhibits enzymes including thermolysin, peptide deformylase, and anthrax lethal factor endopeptidase (LF) produced by the bacterium Bacillus anthracis. Group: Pharmaceutical. CAS No. 142880-36-2. Pack Sizes: 25 mg. Product ID: B0084-302725. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin | Linagliptin is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Uses: The treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 668270-12-0. Pack Sizes: 2.5 g. Product ID: NP2669. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurities | Linagliptin Impurities hold a paramount position in the biomedical sector, instrumental for pharmaceutical research and quality control paradigms. These impurities facilitate the synthesis and evaluation of linagliptin, a pivotal type 2 diabetes treatment via dipeptidyl peptidase-4 enzyme inhibition, thereby assuring the drug's purity and therapeutic effectiveness. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity 10 (S-Isomer) | a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 668270-11-9. Pack Sizes: 50 mg. Product ID: B0012-473823. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity 7 Hydrochloride | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Pack Sizes: 50 mg. Product ID: B1370-449757. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity B | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 2138392-83-1. Pack Sizes: 10 mg. Product ID: B2694-473825. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity E | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 1446263-38-2. Pack Sizes: 10 mg. Product ID: B2694-242668. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Methyldimer | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 1418133-47-7. Pack Sizes: 10 mg. Product ID: B2694-473827. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin N-Acetyl Impurity | An impurity of Linagliptin. Linagliptin is a dipeptidyl peptidase-4 inhibitor with a hpyerglycemic activity. It was approved for the treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1803079-49-3. Pack Sizes: 50 mg. Product ID: B0012-007233. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin N-Boc Impurity | An impurity of Linagliptin. Linagliptin is a dipeptidyl peptidase-4 inhibitor with a hpyerglycemic activity. It was approved for the treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 668273-75-4. Pack Sizes: 50 mg. Product ID: B0012-007234. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Milbemycin oxime | Milbemycin oxime is a semi-synthetic macrolide. As a nematocide and insecticide in veterinary medicine, it opens glutamate sensitive chloride channels in neurons of invertebrates that leads to paralysis by hyperpolarisation of these cells and signal transfer blocking. M1-family aminopeptidase: IC50=2.6 μM (Plasmodium falciparum 3D7); Bile acid transporter: IC50=3.6 μM (human); TGR5: IC50=36.4 μM (human); HCT-116: IC50 >50 μM (human); GBM: IC50 >50 μM (human). Uses: A broad spectrum insecticide; used for treatment and prevention of heartworm in dogs and cats. Group: Pharmaceutical. CAS No. 129496-10-2. Pack Sizes: 500 mg. Product ID: BBF-03816. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-acetic acid-1-amino-3-adamantanol | An impurity of Vildagliptin. Vildagliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Group: Pharmaceutical. CAS No. 1032564-18-3. Pack Sizes: 500 mg. Product ID: B2694-485169. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Acetyl Sitagliptin | N-Acetyl Sitagliptin is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1379666-94-0. Pack Sizes: 50 mg. Product ID: B2694-479646. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Cyano-N'-methyl-ethanimidamide | N-Cyano-N'-methyl-ethanimidamide has exhibited significant inhibitory activity against the dipeptidyl peptidase IV (DPP-4), which represents a pharmacological target for mitigating type 2 diabetes. In addition to this, the product has demonstrated antiviral potential against a diverse range of viral strains, among which the human immunodeficiency virus (HIV) is notable. The product's diverse clinical applications thus mandate in-depth investigation and analysis. Group: Pharmaceutical. CAS No. 56563-12-3. Pack Sizes: 5 g. Product ID: B1370-015289. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Omapatrilat | Omapatrilat, an octahydropyridothiazepine derivative, has been found to be an ACE inhibitor as well as an endopeptidase inhibitor and was once studied in heart failure and hypertension. Uses: For research use only. Group: Pharmaceutical. CAS No. 167305-00-2. Pack Sizes: 10 mg. Product ID: B0084-340551. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Omarigliptin | Omarigliptin is a potent and selective dipeptidyl peptidase 4 (DPP-4) inhibitor to be used as the treatment for type 2 diabetes. Group: Pharmaceutical. CAS No. 1226781-44-7. Pack Sizes: 25 mg. Product ID: B0084-462292. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Pepsin | Pepsin is an endopeptidase produced in the chief cells of the stomach lining. Group: Pharmaceutical. CAS No. 9001-75-6. Pack Sizes: 100 g. Product ID: B2699-079177. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| PMPA sodium salt | PMPA is an inhibitor of glutamate carboxypeptidase 2 (GCP II/N-acetylated a-linked dipeptidase/NAALADase). Group: Pharmaceutical. CAS No. 373645-42-2. Pack Sizes: 50 mg. Product ID: B2693-342069. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzamide | (R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzamide is an impurity of alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor in the class of oral antidiabetic drugs. Group: Pharmaceutical. CAS No. 1820685-30-0. Pack Sizes: 100 mg. Product ID: B1370-377540. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rac-Sitagliptin | Rac-Sitagliptin is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Uses: Dipeptidyl-peptidase iv inhibitors. Group: Pharmaceutical. CAS No. 823817-56-7. Pack Sizes: 50 mg. Product ID: B2693-211737. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Rac-Vildagliptin Impurity F | An impurity of Vildagliptin. Vildagliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Group: Pharmaceutical. CAS No. 1789703-36-1. Pack Sizes: 10 mg. Product ID: B2694-485167. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sacubitril Impurity 4 | Sacubitrilat is one of the impurities of Sacubitril which has been found to be an endopeptidase inhibitor and be effective in the treatment of hypertension and heart failure. Group: Pharmaceutical. CAS No. 149709-44-4. Pack Sizes: 100 mg. Product ID: B0084-475830. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Saxagliptin Cyclic Amidine Impurity | An impurity of saxagliptin.Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. Group: Pharmaceutical. CAS No. 1350800-76-8. Pack Sizes: 5 mg. Product ID: B0016-479455. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Saxagliptin Impurity 15 | An impurity of saxagliptin. Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type II diabetes. Group: Pharmaceutical. CAS No. 1496712-39-0. Pack Sizes: 2.5 mg. Product ID: B0016-479445. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Saxagliptin Impurity 7 | An impurity of saxagliptin.Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. Group: Pharmaceutical. CAS No. 1350800-77-9. Pack Sizes: 2.5 mg. Product ID: B0016-479457. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Saxagliptin Keto Impurity | An impurity of Saxagliptin. Saxagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) used as a hypoglycemic drug. It was approved to treat type 2 diabetes. Group: Pharmaceutical. Pack Sizes: 2.5 mg. Product ID: B0016-007239. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin EP Impurity A Phosphate | Sitagliptin EP Impurity A Phosphate is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 823817-58-9. Pack Sizes: 100 mg. Product ID: B0017-479659. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin EP Impurity B | Sitagliptin EP Impurity B is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 486460-31-5. Pack Sizes: 25 mg. Product ID: B2694-479656. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin EP Impurity B Phosphate | Sitagliptin EP Impurity B Phosphate is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1345822-87-8. Pack Sizes: 10 mg. Product ID: B2694-179047. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin EP Impurity C | Sitagliptin EP Impurity C is a impurity of Sitagliptin. Sitagliptin is an dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 945261-48-3. Pack Sizes: 100 mg. Product ID: B2694-352408. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin EP Impurity C Phosphate | Sitagliptin EP Impurity C Phosphate is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1345822-86-7. Pack Sizes: 30 mg. Product ID: B2694-174790. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin FP Impurity B | Sitagliptin FP Impurity B is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 2088771-61-1. Pack Sizes: 5 mg. Product ID: B2694-334170. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin FP Impurity E Hydrochloride | Sitagliptin EP Impurity E is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1204818-19-8. Pack Sizes: 1 g. Product ID: BAT-008056. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin Fumarate Adduct (Mixture of Diastereomers) | Sitagliptin Fumarate Adduct is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 2088771-60-0. Pack Sizes: 50 mg. Product ID: B2694-032361. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin Impurity 40 HCl | Sitagliptin Impurity 40 HCl is an impurity of Sitagliptin. Sitagliptin is an dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1374985-05-3. Pack Sizes: 500 mg. Product ID: B2694-186710. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin phenylcrotonyl analog | Sitagliptin phenylcrotonyl analog is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1253056-18-6. Pack Sizes: 10 mg. Product ID: B0017-479654. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin Phosphate Monohydrate | Sitagliptin Phosphate Monohydrate is the phosphate salt form of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 654671-77-9. Pack Sizes: 100 g. Product ID: B2692-335254. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin styrylacetyl analog | Sitagliptin styrylacetyl analog is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1803026-58-5. Pack Sizes: 10 mg. Product ID: B0017-004064. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (S)-Sitagliptin N-Boc-Acid Impurity | (S)-Sitagliptin N-Boc-Acid Impurity is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 922178-94-7. Pack Sizes: 1 g. Product ID: BAT-008080. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Talabostat mesylate | Talabostat mesylate is the orally bioavailable mesylate salt of an amino boronic dipeptide with antineoplastic and hematopoiesis- stimulating activities. By cleaving N-terminal Xaa-Pro or Xaa-Ala residues, talabostat inhibits dipeptidyl peptidases, such as fibroblast activation protein (FAP), resulting in the stimulation of cytokine and chemokine production and specific T-cell immunity and T-cell- dependent activity. This agent may also stimulate the production of colony stimulating factors, such as granulocyte colony stimulating factor (G-CSF), resulting in the stimulation of hematopoiesis. Dipeptidyl peptidases are involved in the activation of polypeptide hormones and chemokines. Uses: For research used only. Group: Pharmaceutical. CAS No. 150080-09-4. Pack Sizes: 20 mg. Product ID: B0084-084554. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Teneligliptin | Teneligliptin is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor. It competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro. Group: Pharmaceutical. CAS No. 760937-92-6. Pack Sizes: 250 mg. Product ID: B0084-461910. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Teneligliptin HBr | Teneligliptin hydrobromide is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor. It competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro. Group: Pharmaceutical. CAS No. 906093-29-6. Pack Sizes: 250 mg. Product ID: B0084-463677. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Tosedostat | Tosedostat is an aminopeptidase inhibitor for LAP, PuSA and Aminopeptidase N with IC50 of 100 nM, 150 nM and 220 nM, respectively, and does not effectively inhibit either PILSAP, MetAP-2, LTA4 hydrolase, or MetAP-2 with IC50 values are > 1000, > 5000, > 10000 and > 30000 nM for aminopeptidase B, PILSAP, LTA4 hydrolase and MetAP2 respectively. Phase 2. Tosedostat potently inhibits tumor cell proliferation in a variety of tumor cell lines in vitro and in vivo. Group: Pharmaceutical. CAS No. 238750-77-1. Pack Sizes: 100 mg. Product ID: B0084-088218. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
